These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7789044)

  • 21. Hepatic subcapsular steatosis as a complication associated with intraperitoneal insulin treatment in diabetic peritoneal dialysis patients.
    Torun D; Oguzkurt L; Sezer S; Zumrutdal A; Singan M; Adam FU; Ozdemir FN; Haberal M
    Perit Dial Int; 2005; 25(6):596-600. PubMed ID: 16411528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Permanent control of blood glucose in diabetic patients using continuous ambulatory peritoneal dialysis. Continuous insulin infusion by the intraperitoneal route].
    Martinand A; Belleville I; Cabanne JF; Chuet C; Morey W; Brun JM; Rifle G
    Presse Med; 1984 Jan; 13(3):165. PubMed ID: 6229747
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.
    Mactier RA; Moore H; Khanna R; Shah J
    Nephron; 1990; 54(3):240-4. PubMed ID: 2179758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes.
    Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5761-4. PubMed ID: 16091481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.
    Riveline JP; Vantyghem MC; Fermon C; Brunet C; Gautier JF; Renard E; Charpentier G;
    Diabetes Metab; 2005 Nov; 31(5):496-8. PubMed ID: 16357794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus.
    Bagdade JD; Dunn FL
    Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No change in apolipoprotein AI metabolism when subcutaneous insulin infusion is replaced by intraperitoneal insulin infusion in type 1 diabetic patients.
    Duvillard L; Florentin E; Baillot-Rudoni S; Lalanne-Mistrich ML; Brun-Pacaud A; Petit JM; Brun JM; Gambert P; Vergès B
    Atherosclerosis; 2007 Oct; 194(2):342-7. PubMed ID: 17141785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus.
    Selam JL; Kashyap M; Alberti KG; Lozano J; Hanna M; Turner D; Jeandidier N; Chan E; Charles MA
    Metabolism; 1989 Sep; 38(9):908-12. PubMed ID: 2671601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus.
    Dunn FL; Pietri A; Raskin P
    Ann Intern Med; 1981 Oct; 95(4):426-31. PubMed ID: 7025720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
    Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
    Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of continuous insulin infusion therapy on lipoprotein surface and core lipid composition in insulin-dependent diabetes mellitus.
    Bagdade JD; Helve E; Taskinen MR
    Metabolism; 1991 May; 40(5):445-9. PubMed ID: 2023530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
    Grefberg N; Danielson BG; Berne C
    J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion.
    Lager I; Lönnroth P; von Schenck H; Smith U
    Br Med J (Clin Res Ed); 1983 Dec; 287(6406):1661-4. PubMed ID: 6416540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study.
    Selgas R; Diez JJ; Muñoz J; Miranda B; de Alvaro F; Rodriguez JC
    Adv Perit Dial; 1989; 5():181-4. PubMed ID: 2577407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance in multiple tissues in patients with type 1 diabetes mellitus on long-term continuous subcutaneous insulin infusion therapy.
    Donga E; van Dijk M; Hoogma RP; Corssmit EP; Romijn JA
    Diabetes Metab Res Rev; 2013 Jan; 29(1):33-8. PubMed ID: 22936679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous ambulatory peritoneal dialysis in diabetic patients with end-stage renal disease: experience with intraperitoneal insulin therapy.
    Chen HC; Lai YH; Tsai CY; Shin SJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Feb; 7(2):56-61. PubMed ID: 2005672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous intraperitoneal insulin infusion partly restores the glucagon response to hypoglycaemia in type 1 diabetic patients.
    Oskarsson PR; Lins PE; Backman L; Adamson UC
    Diabetes Metab; 2000 Apr; 26(2):118-24. PubMed ID: 10804326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraperitoneal (125I) insulin absorption during intermittent and continuous peritoneal dialysis.
    Wideröe TE; Smeby LC; Berg KJ; Jörstad S; Svartås TM
    Kidney Int; 1983 Jan; 23(1):22-8. PubMed ID: 6339786
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.